Clinical Trials · NCT07109700
A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Enrollment
- 216
- Start date
- Apr 2025
- Locations
- 1 site, China
- Primary endpoint
- Change from baseline in Hemoglobin A1c (HbA1c)